Berobenatide for obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 26 Oct 2026: Trial started, NCT07915609
  2. 4 Nov 2026: Trial registered, NCT07915609

The trials

NCT07915609: A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)

State
Under way
Phase
Phase 3
People
756 planned
Started
26 Oct 2026
Primary completion
21 Aug 2028
Arms
Arm 1: Berobenatide Once Weekly, Arm 2: Berobenatide Once Weekly, Arm 3: Berobenatide Once Weekly
Results
None posted
  1. 26 Oct 2026: Trial started
  2. 4 Nov 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.